BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22573115)

  • 1. Possible KIR-driven genetic pressure on the genesis and maintenance of specific HLA-A,B haplotypes as functional genetic blocks.
    Capittini C; Tinelli C; Guarene M; Pasi A; Badulli C; Sbarsi I; Garlaschelli F; Cremaschi AL; Pizzochero C; Monti C; Salvaneschi L; Martinetti M
    Genes Immun; 2012 Sep; 13(6):452-7. PubMed ID: 22573115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distribution of KIR-HLA functional blocks is different from north to south of Italy.
    Fasano ME; Rendine S; Pasi A; Bontadini A; Cosentini E; Carcassi C; Capittini C; Cornacchini G; Espadas de Arias A; Garbarino L; Carella G; Mariotti ML; Mele L; Miotti V; Moscetti A; Nesci S; Ozzella G; Piancatelli D; Porfirio B; Riva MR; Romeo G; Tagliaferri C; Lombardo C; Testi M; Amoroso A; Martinetti M
    Tissue Antigens; 2014 Mar; 83(3):168-73. PubMed ID: 24571475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class I variation in Iranian Lur and Kurd populations: high haplotype and allotype diversity with an abundance of KIR ligands.
    Ashouri E; Norman PJ; Guethlein LA; Han AS; Nemat-Gorgani N; Norberg SJ; Ghaderi A; Parham P
    HLA; 2016 Sep; 88(3):87-99. PubMed ID: 27558013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
    Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A
    Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of HLA-A, -B, and -C alleles and HLA/KIR combinations in Han population in China.
    Shen Y; Cao D; Li Y; Kulski JK; Shi L; Jiang H; Ma Q; Yu J; Zhou J; Yao Y; Shi L
    J Immunol Res; 2014; 2014():565296. PubMed ID: 24995346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association of genetic polymorphisms of KIR-HLA system with chronic myeloid leukemia among ethnic Hans from southern China].
    Deng Z; Zhen J; Wang D; He L; Zou H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Feb; 34(1):53-57. PubMed ID: 28186594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIR genes and HLA class I ligands in a Caucasian Brazilian population with colorectal cancer.
    Portela P; Merzoni J; Lindenau JD; Damin DC; Wilson TJ; Roesler R; Schwartsmann G; Jobim LF; Jobim M
    Hum Immunol; 2017 Mar; 78(3):263-268. PubMed ID: 28088355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of sub-Saharan Africans.
    Norman PJ; Hollenbach JA; Nemat-Gorgani N; Guethlein LA; Hilton HG; Pando MJ; Koram KA; Riley EM; Abi-Rached L; Parham P
    PLoS Genet; 2013 Oct; 9(10):e1003938. PubMed ID: 24204327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.
    Mirzazadeh S; Bemani P; Halimi H; Sanaee MN; Karami N; Ramzi M; Farjadian S
    Sci Rep; 2023 Jul; 13(1):11456. PubMed ID: 37454198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
    Littera R; Chessa L; Onali S; Figorilli F; Lai S; Secci L; La Nasa G; Caocci G; Arras M; Melis M; Cappellini S; Balestrieri C; Serra G; Conti M; Zolfino T; Casale M; Casu S; Pasetto MC; Barca L; Salustro C; Matta L; Scioscia R; Zamboni F; Faa G; Orrù S; Carcassi C
    PLoS One; 2016; 11(1):e0146086. PubMed ID: 26744892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of KIR3DL1 expression levels on 92 cases of normal donors for hematopoietic stem cells transplant].
    Zhang J; Wang M; Bao X; Wu X; Zhou H; Zhang H; Wu D; He J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Dec; 36(12):994-8. PubMed ID: 26759099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation.
    McQueen KL; Dorighi KM; Guethlein LA; Wong R; Sanjanwala B; Parham P
    Hum Immunol; 2007 May; 68(5):309-23. PubMed ID: 17462498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.
    Verheyden S; Ferrone S; Mulder A; Claas FH; Schots R; De Moerloose B; Benoit Y; Demanet C
    Cancer Immunol Immunother; 2009 Jun; 58(6):855-65. PubMed ID: 18841361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.
    Tajik N; Shahsavar F; Poormoghim H; Radjabzadeh MF; Mousavi T; Jalali A
    Int J Immunogenet; 2011 Oct; 38(5):403-9. PubMed ID: 21797986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis.
    Karlsen TH; Boberg KM; Olsson M; Sun JY; Senitzer D; Bergquist A; Schrumpf E; Thorsby E; Lie BA
    J Hepatol; 2007 May; 46(5):899-906. PubMed ID: 17383044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIR specificity and avidity of standard and unusual C1, C2, Bw4, Bw6 and A3/11 amino acid motifs at entire HLA:KIR interface between NK and target cells, the functional and evolutionary classification of HLA class I molecules.
    Gwozdowicz S; Nestorowicz K; Graczyk-Pol E; Szlendak U; Rogatko-Koros M; Mika-Witkowska R; Pawliczak D; Zubala M; Malinowska A; Witkowska A; Nowak J
    Int J Immunogenet; 2019 Aug; 46(4):217-231. PubMed ID: 31210416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B.
    Thananchai H; Gillespie G; Martin MP; Bashirova A; Yawata N; Yawata M; Easterbrook P; McVicar DW; Maenaka K; Parham P; Carrington M; Dong T; Rowland-Jones S
    J Immunol; 2007 Jan; 178(1):33-7. PubMed ID: 17182537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.
    Mahmoudi M; Fallahian F; Sobhani S; Ghoroghi S; Jamshidi A; Poursani S; Dolati M; Hosseinpour Z; Gharibdoost F
    Clin Rheumatol; 2017 Apr; 36(4):853-862. PubMed ID: 28120169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIR-HLA-A and B alleles of the Bw4 epitope against HIV infection in discordant heterosexual couples in Chaco Argentina.
    Habegger de Sorrentino A; Sinchi JL; Marinic K; López R; Iliovich E
    Immunology; 2013 Oct; 140(2):273-9. PubMed ID: 23789883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIR and HLA genotypes predictive of low-affinity interactions are associated with lower relapse in autologous hematopoietic cell transplantation for acute myeloid leukemia.
    Marra J; Greene J; Hwang J; Du J; Damon L; Martin T; Venstrom JM
    J Immunol; 2015 May; 194(9):4222-30. PubMed ID: 25810393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.